Physician profile
Mary Jo Sarver
NPI 1154672384
$72,202.71
in general payments reported to CMS, 2019-2025
10 companies · $3,009 in 2025
The $3,009 reported for 2025 was more than what 99% of Registered Nurse providers received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,081 · 2022: $27K · 2023: $21K · 2024: $16K · 2025: $3,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $13K · Food and Beverage: $1,679 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,485.35 |
| Travel and Lodging | $13,371.75 |
| Food and Beverage | $1,678.84 |
| Education | $278.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $49,140.04 | 2022-2025 | Libtayo |
| Genzyme Corporation | $22,261.88 | 2021-2024 | |
| Incyte Corporation | $179.95 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $168.35 | 2022-2024 | Reblozyl |
| Janssen Biotech, INC. | $163.71 | 2022-2023 | Darzalex, Imbruvica |
| Seagen INC. | $99.00 | 2024 | |
| Amgen INC. | $94.99 | 2022-2023 | Xgeva, Nplate |
| Astrazeneca Pharmaceuticals Lp | $36.34 | 2022 | |
| Tersera Therapeutics LLC | $34.62 | 2023 | Zoladex |
| Genentech USA, INC. | $23.83 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Jo Sarver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.